市場調査レポート

商品コード

1707952

組織診断の市場規模、シェア、成長分析、製品タイプ別、技術別、疾患タイプ別、モダリティ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Tissue Diagnostics Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization), By Disease Type, By Modality, By End-user, By Region - Industry Forecast 2025-2032

出版日: 2025年04月09日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 775,496円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 907,184円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,038,872円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.32円

全表示
概要
目次

概要

サンプル依頼リストに入れる

組織診断の世界市場規模は2023年に54億米ドルと評価され、2024年の58億6,000万米ドルから2032年には113億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.6％で成長する見通しです。

組織診断市場は、がん罹患率の上昇を原動力に大きく成長する見通しです。COVID-19のパンデミックは、ウイルス封じ込めにリソースを割いたため診断検査に一時的な支障をきたしたが、ヘルスケアシステムが新たな標準に適応するにつれて市場は回復しています。正確な診断と疾患モニタリング、特にがんに対する需要は高まっています。解剖学的病理学の進歩は臨床病理学の継続的拡大を促進し、解剖学的病理学と分子病理学の統合はますます顕著になっています。がん診断のためのリキッドバイオプシーの採用は増加し、計算病理学の重要性の高まりはバイオインフォマティクスの重要性を強調しています。過去20年間、この分野では診断ツールが強化され、病理医や臨床医の診療に革命をもたらしてきました。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

F. Hoffmann-La Roche Ltd.（Switzerland）
Abbott Laboratories（USA）
Thermo Fisher Scientific Inc.（USA）
Siemens Healthineers（Germany）
Danaher Corporation（USA）
bioMerieux SA（France）
QIAGEN N.V.（Netherlands）
Becton, Dickinson and Company（BD）（USA）
Merck KGaA（Germany）
GE Healthcare（USA）
BioGenex Laboratories（USA）
Cell Signaling Technology, Inc.（USA）
Bio SB（USA）
DiaGenic ASA（Norway）
Agilent Technologies（USA）
Fujirebio Inc.（Japan）
Tecan Group Ltd.（Switzerland）
STRATEC SE（Germany）
Seegene Inc.（South Korea）
Leica Biosystems（Germany）

結論と提言

Product Code: SQMIG35H2161

Global Tissue Diagnostics Market size was valued at USD 5.4 billion in 2023 and is poised to grow from USD 5.86 billion in 2024 to USD 11.35 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032).

The tissue diagnostics market is poised for significant growth driven by the rising incidence of cancer. Although the COVID-19 pandemic temporarily hindered diagnostic testing due to resource allocation towards virus containment, the market is rebounding as healthcare systems adapt to new normals. The demand for precise diagnosis and disease monitoring, particularly for cancer, is escalating. Advances in anatomic pathology are fostering the continuous expansion of clinical pathology, while the integration of anatomical and molecular pathology is increasingly evident. The adoption of liquid biopsies for cancer diagnosis is rising, and the growing relevance of computational pathology emphasizes the importance of bioinformatics. Over the past two decades, the sector has seen enhanced diagnostic tools, revolutionizing the practice for pathologists and clinicians.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Diagnostics Market Segments Analysis

Global Tissue Diagnostics Market is segmented by Product Type, Technology, Disease Type, Modality, End-user and region. Based on Product Type, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Anatomic Pathology, Molecular Pathology, Digital Pathology & Workflow Management and Special Staining. Based on Disease Type, the market is segmented into Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Cell Lung Cancer and Others. Based on Modality, the market is segmented into Clinical and Pharma / CRO / Research Market. Based on End-user, the market is segmented into Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Diagnostics Market

A significant driving force behind the expansion of the global tissue diagnostics market is the rising incidence of chronic diseases, notably cancer. With cancer rates escalating worldwide, the need for swift and precise diagnostic solutions becomes crucial, as early detection significantly increases the likelihood of successful treatment. Innovations in tissue diagnostics, such as immunohistochemistry and molecular pathology, have enhanced the ability of healthcare professionals to identify various tumor types and subtypes accurately. The growing demand for reliable diagnostic tools compels healthcare providers to invest in cutting-edge tissue diagnostics technologies, thereby fostering market growth and enhancing the quality of care for cancer patients.

Restraints in the Global Tissue Diagnostics Market

The Global Tissue Diagnostics market faces significant restraint due to the high costs associated with modern tissue diagnostic techniques. Advanced diagnostic tools and methodologies often come with substantial price tags that can be unaffordable for smaller hospitals and laboratories. The expenses related to equipment, training, and ongoing maintenance further complicate the situation. This financial barrier can hinder access to the latest diagnostic tests, particularly in developing nations where healthcare resources are limited. Consequently, the slow adoption of cutting-edge tissue diagnostics in certain areas restricts the availability of accurate diagnostic tools for patients, impeding overall market growth in this sector.

Market Trends of the Global Tissue Diagnostics Market

The Global Tissue Diagnostics market is witnessing a significant trend towards personalized healthcare, driven by an increasing emphasis on tailored therapies that cater to individual genetic profiles. This shift reflects the need for advanced diagnostic tools capable of identifying specific biomarkers critical for accurate disease characterization. With advancements in genetic profiling and molecular diagnostics, healthcare professionals are equipped to design customized treatment plans that enhance patient outcomes. Consequently, this demand is propelling innovation within the tissue diagnostics sector, as stakeholders strive to develop more precise and effective diagnostic technologies, ultimately leading to improved patient care and a more targeted approach to treatment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Tissue Diagnostics Market Size by Product Type & CAGR (2025-2032)

Market Overview
Consumables
- Antibodies
- Kits
- Reagents
- Probes
Instruments
- Slide-staining Systems
- Scanners
- Tissue-processing Systems
- Other Instruments

Global Tissue Diagnostics Market Size by Technology & CAGR (2025-2032)

Market Overview
Immunohistochemistry
In Situ Hybridization
Primary & Special Staining
Anatomic Pathology
Molecular Pathology
Digital Pathology & Workflow Management
Special Staining

Global Tissue Diagnostics Market Size by Disease Type & CAGR (2025-2032)

Market Overview
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-small Cell Lung Cancer
Others

Global Tissue Diagnostics Market Size by Modality & CAGR (2025-2032)

Market Overview
Clinical
Pharma / CRO / Research Market

Global Tissue Diagnostics Market Size by End-user & CAGR (2025-2032)

Market Overview
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations (CROs)
Others

Global Tissue Diagnostics Market Size & CAGR (2025-2032)

North America (Product Type, Technology, Disease Type, Modality, End-user)
- US
- Canada
Europe (Product Type, Technology, Disease Type, Modality, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Disease Type, Modality, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Disease Type, Modality, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Disease Type, Modality, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio SB (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaGenic ASA (Norway)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujirebio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STRATEC SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

組織診断の市場規模、シェア、成長分析、製品タイプ別、技術別、疾患タイプ別、モダリティ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Tissue Diagnostics Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization), By Disease Type, By Modality, By End-user, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

組織診断市場規模：製品タイプ別& CAGR（2025-2032）

組織診断市場規模：技術別& CAGR（2025-2032）

組織診断市場規模：疾患タイプ別& CAGR（2025-2032）

組織診断市場規模：モダリティ別& CAGR（2025-2032）

組織診断市場規模：エンドユーザー別& CAGR（2025-2032）

組織診断市場規模：地域別& CAGR（2025-2032）